Contrast Induced Acute Kidney Injury (CI- AKI) - Myths and realities

Authors

Kulwant Singh, Consultant, Department of Renal Sciences, Ivy Hospital, Mohali, Punjab.
Vinant Bhargava, Consultant, Institute of Renal Sciences, Department of Nephrology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi.
Jyoti E. Brar, Advocate Aurora Health
Mrinal Bhargava, Senior Consultant, Department of Medicine, Kailash Hospital, Noida, Uttar Pradesh.
Raka Kaushal, Senior Consultant, Department of Renal Sciences, Ivy hospital, Mohali, Punjab.
Dinesh Khullar, Chairman, Department of Nephrology, Max Super Specialty Hospital, Saket, New Delhi.

Recommended Citation

Singh K, Bhargava V, Brar JE, Bhargava M, Kaushal R, Khullar D. Contrast Induced Acute Kidney Injury (CI- AKI) - Myths and Realities. J Assoc Physicians India. 2021;69(11):11-12.

Affiliations

Aurora Health Care

Abstract

Contrast Induced Acute Kidney Injury (CI-AKI) is one of the most common causes of acute kidney injury in hospitalized patients. These days, contrast agents are widely being used in both cardiology and radiology procedures. Old age, history of diabetes, heart failure, proteinuria and low blood pressure are some important risk factors in the pathogenesis of CI-AKI. Apart from risk stratification and the use of low and iso-osmolar contrast agents, intravenous fluid hydration with crystalloids is the only recommended strategy for the prevention of CI-AKI. Agents like N-acetylcysteine (NAC), atrial natriuretic peptide, ascorbic acid, theophylline, and fenoldopam have failed to show any proven beneficial role in the prevention of CI-AKI. Though hemodialysis is still being perceived by many clinicians as the modality for contrast removal but prophylactic hemodialysis is now not recommended for the prevention of CI-AKI.

Document Type

Article

PubMed ID

34781617